References
- Kessinger A. Is blood or bone marrow better?. Stem Cells 1988; 11: 290–294
- Gratwohl A., Hermans J. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: Report from the European Group for Blood and Marrow Transplantation (EBMT). Clin Transpl 1995; 9: 355–363
- Bowden R. A., Mayers J. D. Infectious complications following marrow transplantation. Plasma Ther Transfus Technol 1985; 6: 285–302
- Rogers T. R. Infective complications of bone marrow transplantation. Current Opinion in Infectious Diseases 1988; 1: 616–624
- The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of Amikacin for empirical therapy of Gram negative bacteremia in cancer patients with granulocytopenia. New Engl J Med 1987; 317: 1692–8
- Valteau D., Hartmann O., Brugeres L., et al. Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high dose chemotherapy. Bone Marrow Transplant 1991; 7: 415–19
- Louder J. N., Lazzarus H. M., Herzig R. H. Bacteremia and fungemias in oncologic patients with central venous catheters. Arch Int Med 1992; 142: 1456–1459
- Mossad S. B., Longworth D. L., Goormastic M., Serkey J. M., Keys T. F., Bolwell B. J. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265–271
- Bodey G. P., Backley M., Sathe Y. S., et al. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Int Med 1966; 64: 328–340
- De Vita V. T., Hubbard S. M. Hodgkin's disease. New Engl J Med 1993; 328: 560–65
- Atkinson K., Biggs A. J., Pun A. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation. Br J Hematol 1983; 53: 265–270
- Nosanchuk J. D., Sepkowitz K. A., Pearse R. N., White M. H., Nimer S. D., Armstrong D. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 1996; 18: 355–359
- Menichetti F., Del Favero A., Martino P., et al. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral Amphotericin B. Ann Int Med 1994; 120: 913–918
- Girmenia C., Martino P., Cassone A. Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies. Blood 1996; 87: 838–839
- Mascret B., Maraninchi D., Gastaut J. A., et al. Risk factors for Streptococcal septicaemia after marrow transplantation. Lancet 1984; 26: 1185–6
- Altai M., Schlaifer D., Rubie H., et al. Prevention of Gram-positive infections after bone marrow transplantation by systemic Vancomycin: a prospective, randomized trial. J Clin Oncol 1991; 9: 865–70
- Schwarbe R. S., Stapleton J. T., Gillingan P. H. Emergence of Vancomycin resistance in Coagulase-negative Staphylococci. New Engl J Med 1987; 108: 30–35